MyoKardia

YTD

ALL

Why Robinhood?

You can watch MyoKardia and buy or sell other stocks, ETFs, and their options commission-free!

About MYOK

MyoKardia is a clinical-stage biopharmaceutical company that engages in discovering, developing, and commercializing targeted therapies for the treatment of rare cardiovascular diseases. The company's focus is on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction.

CEO

Sandra Ramos-Alves

CEOSandra Ramos-Alves

Employees

—

Employees—

Headquarters

Brisbane, California

HeadquartersBrisbane, California

Founded

2012

Founded2012

Employees

—

Employees—

MYOK Key Statistics

Market cap

11.99B

Market cap11.99B

Price-Earnings ratio

-39.87

Price-Earnings ratio-39.87

Dividend yield

—

Dividend yield—

Average volume

1.31M

Average volume1.31M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$225.00

52 Week high$225.00

52 Week low

$42.65

52 Week low$42.65